Pilulka Lekarny AS (XPRA:PINK) Retained Earnings: Kč-592 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPRA:PINK Pilulka Lekarny AS XPRA:PINK
50 GF Score
Price Kč113.00
GF Value Kč110.10
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Pilulka Lekarny AS Retained Earnings?

Pilulka Lekarny AS XPRA:PINK +2.73% 50 Retained Earnings is Kč-592 Mil as of Dec. 2025. GuruFocus rates XPRA:PINK with a GF Score™ of 50/100 and a GF Value™ of Kč110.10 (Fairly Valued). The stock has 6 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Pilulka Lekarny AS's retained earnings for the quarter that ended in Dec. 2025 was Kč-592 Mil.

Pilulka Lekarny AS's quarterly retained earnings declined from Jun. 2024 (Kč0 Mil) to Dec. 2024 (Kč-553 Mil) and declined from Dec. 2024 (Kč-553 Mil) to Dec. 2025 (Kč-592 Mil).

Pilulka Lekarny AS's annual retained earnings declined from Dec. 2023 (Kč-426 Mil) to Dec. 2024 (Kč-553 Mil) and declined from Dec. 2024 (Kč-553 Mil) to Dec. 2025 (Kč-592 Mil).


Pilulka Lekarny AS  (XPRA:PINK) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Pilulka Lekarny AS Retained Earnings Historical Data

* Premium members only.

The historical data trend for Pilulka Lekarny AS's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pilulka Lekarny AS Retained Earnings Chart

Pilulka Lekarny AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial -188.42 -251.09 -425.77 -552.59 -592.46

Pilulka Lekarny AS Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Jun24 Dec24 Dec25
Retained Earnings Get a 7-Day Free Trial -251.09 -425.77 0.00 -552.59 -592.46
XPRA:PINK
50GF Score
Pilulka Lekarny AS XPRA:PINK
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pilulka Lekarny AS Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of Kč-592 Mil mean?
Pilulka Lekarny AS (XPRA:PINK) has a Retained Earnings of Kč-592 Mil as of Dec. 2025. Retained earnings is the amount of net income not issued to shareholders. View historical data on Pilulka Lekarny AS and its competitors.
Is Pilulka Lekarny AS's Retained Earnings too high?
Pilulka Lekarny AS's current Retained Earnings is Kč-592 Mil. Overall, Pilulka Lekarny AS has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pilulka Lekarny AS's Retained Earnings compare to competitors?
Pilulka Lekarny AS's Retained Earnings of Kč-592 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Healthcare Providers & Services company?
A good Retained Earnings depends on the Healthcare Providers & Services industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Pilulka Lekarny AS and its competitors. Pilulka Lekarny AS's current Retained Earnings is Kč-592 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pilulka Lekarny AS stock overvalued right now?
Based on GuruFocus' analysis, Pilulka Lekarny AS (XPRA:PINK) is currently considered Fairly Valued. The stock's GF Value™ is Kč110.10, compared to a current price of Kč113.00 — trading 2.6% above its estimated fair value. The current Retained Earnings is Kč-592 Mil. Pilulka Lekarny AS's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Pilulka Lekarny AS (XPRA:PINK), the current Retained Earnings is Kč-592 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pilulka Lekarny AS (XPRA:PINK) Overvalued in 2026?

Based on GuruFocus' analysis, Pilulka Lekarny AS stock appears to be overvalued. The current stock price of Kč113.00 is trading 2.6% above its estimated GF Value™ of Kč110.10. GuruFocus considers Pilulka Lekarny AS to be Fairly Valued.

Key valuation signals for XPRA:PINK:

  • Retained Earnings: Kč-592 Mil
  • GF Value™: Kč110.10 vs. price of Kč113.00 (2.6% above fair value)
  • GF Score™: 50/100 with 6 warning signs

No single metric tells the full story. See the XPRA:PINK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pilulka Lekarny AS Business Description

Address Drahobejlova 1073/36, Prague, CZE, 190 00
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
50GF Score

Get the complete analysis for XPRA:PINK

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Kč113.00
Price
Kč110.10
GF Value